Latest Breaking News On - Centered outcomes research - Page 4 : comparemela.com
PCORI approves $254 million to fund 28 new research studies addressing urgent health problems
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
PCORI approves $254 million to fund 28 new research studies addressing urgent health problems
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
PCORI approves $11 million for new studies to boost COVID-19 vaccination rates among long-term care workers
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
PCORI approves $11 million for new studies to boost COVID-19 vaccination rates among long-term care workers
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Share this article
Share this article
WASHINGTON, March 16, 2021 /PRNewswire/ Patients, clinicians and families facing uncertainty about their choices for managing Type 2 diabetes and rare diseases will gain new evidence to inform their decision making from comparative clinical effectiveness research (CER) studies that the Patient-Centered Outcomes Research Institute (PCORI) Board of Governors today approved for a total of $42.7 million in new funding.
The PCORI Board approved another $5.8 million for four projects that aim to accelerate the adoption of useful findings from completed PCORI-funded research in clinical care. The Board also approved PCORI s CER funding announcements on three topics: maternal health, urinary incontinence and mental health among people with intellectual and developmental disabilities.